SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 64 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $27,826,000 | +16.3% | 2,303,462 | -20.0% | 11.83% | +74.1% |
| Q4 2014 | $23,927,000 | -4.4% | 2,879,328 | 0.0% | 6.80% | -54.6% |
| Q3 2014 | $25,021,000 | -36.4% | 2,879,328 | -20.0% | 14.96% | -18.2% |
| Q2 2014 | $39,348,000 | +22.4% | 3,600,000 | 0.0% | 18.28% | +3.1% |
| Q1 2014 | $32,148,000 | +18.6% | 3,600,000 | 0.0% | 17.74% | -13.2% |
| Q4 2013 | $27,108,000 | +2.9% | 3,600,000 | 0.0% | 20.43% | +36.0% |
| Q3 2013 | $26,352,000 | +13.7% | 3,600,000 | 0.0% | 15.02% | -15.8% |
| Q2 2013 | $23,184,000 | – | 3,600,000 | – | 17.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |